Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Johnson and Johnson
AstraZeneca
McKesson
Colorcon

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR METHYLPREDNISOLONE SODIUM SUCCINATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Methylprednisolone Sodium Succinate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000579 ↗ Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1994-09-01 The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.
NCT00097448 ↗ Sudden Deafness Treatment Trial Completed National Institute on Deafness and Other Communication Disorders (NIDCD) Phase 3 2004-12-01 This trial aims to compare the efficacy of oral prednisone vs. methylprednisolone injected into the middle ear for the treatment of moderate-to-severe, sudden sensorineural hearing loss (inner ear hearing loss affecting one ear that occurs over less than 72 hours).
NCT00097448 ↗ Sudden Deafness Treatment Trial Completed Massachusetts Eye and Ear Infirmary Phase 3 2004-12-01 This trial aims to compare the efficacy of oral prednisone vs. methylprednisolone injected into the middle ear for the treatment of moderate-to-severe, sudden sensorineural hearing loss (inner ear hearing loss affecting one ear that occurs over less than 72 hours).
NCT00185692 ↗ Allogeneic Transplantation From Related Haploidentical Donors Completed Stanford University Phase 2 2000-08-01 The purpose of the study is to evaluate the feasibility and safety of transplanting CD34+ selected hematopoietic cells from a haploidentical related donor following a nonmyeloablative regimen of total lymphoid irradiation (TLI) and antithymocyte globulin (ATG).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Methylprednisolone Sodium Succinate

Condition Name

Condition Name for Methylprednisolone Sodium Succinate
Intervention Trials
Leukemia 3
Spinal Cord Injuries 2
Acute Respiratory Distress Syndrome 2
Lung Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Methylprednisolone Sodium Succinate
Intervention Trials
Syndrome 6
Leukemia 4
Respiratory Distress Syndrome, Newborn 3
Respiratory Distress Syndrome, Adult 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Methylprednisolone Sodium Succinate

Trials by Country

Trials by Country for Methylprednisolone Sodium Succinate
Location Trials
United States 83
Canada 9
Australia 5
China 2
New Zealand 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Methylprednisolone Sodium Succinate
Location Trials
California 5
Maryland 4
Massachusetts 4
Texas 3
North Carolina 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Methylprednisolone Sodium Succinate

Clinical Trial Phase

Clinical Trial Phase for Methylprednisolone Sodium Succinate
Clinical Trial Phase Trials
Phase 4 5
Phase 3 10
Phase 2/Phase 3 1
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Methylprednisolone Sodium Succinate
Clinical Trial Phase Trials
Completed 17
Recruiting 6
Terminated 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Methylprednisolone Sodium Succinate

Sponsor Name

Sponsor Name for Methylprednisolone Sodium Succinate
Sponsor Trials
National Cancer Institute (NCI) 4
Stanford University 2
National Heart, Lung, and Blood Institute (NHLBI) 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Methylprednisolone Sodium Succinate
Sponsor Trials
Other 46
NIH 8
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Harvard Business School
Dow
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.